OVERVIEW

Reducing Clinical Inertia in Type 2 Diabetes: A Case for Early Combination Therapy is organized by Healthcare Made Practical (HMP) Communications LLC and will be held from Oct 16, 2018 - Oct 16, 2019.

Target Audience:
This activity is designed for primary care physicians, family medicine specialists, internists, pediatricians, nurse practitioners, nurses, physician assistants, pharmacists, registered dietitians, certified diabetes educators, and other related healthcare professionals involved in the treatment of patients at risk for cardiometabolic syndrome.

Accreditation:
0.75 CME
0.75 CNE
0.75 CPE

Course Overview:
To be eligible for documentation of credit, participants must complete the educational activity, complete the 10 question post-test with a score of 70% or better, and complete the evaluation form.

After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Course Objectives:
After completing this activity, participants should be able to:

• Outline the benefits and risks of various classes of antihyperglycemic agents for the treatment of type 2 diabetes mellitus
• Review current guideline recommendations for the initiation and intensification of therapy in patients with type 2 diabetes mellitus
• Discuss the rationale, role, and potential benefits of fixed-dose combinations
• Design individualized treatment plans for timely achievement of glycemic goals

Additional details will be posted as soon as they are available.